Goldman Sachs Upgrades Bruker (BRKR) to Buy; Turnaround Story

Article Stock Quotes (1) Comments (0)

Goldman Sachs upgraded Bruker (NASDAQ: BRKR) from Neutral to Buy with a price target of $19.00 (from $13.00), suggesting 40% upside.

The firm comments, "After underperforming Tools peers by 1000bp YTD, we see a turnaround story for 2013 with healthy organic growth, margin expansion, and an attractive risk/reward profile coupled with the following catalysts: (1) better-than-expected strength in core end markets, (2) pending detail on long-term margin expansion plans, and (3) low expectations/valuation that sets up a "laggards to leader" trade."

For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.

Shares of Bruker closed at $13.61 yesterday, with a 52 week range of $9.91-$17.10.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
• Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)
• Goldman Sachs Upgrades Ruckus Wireless (RKUS) to Buy, 'Pullback Creates Opportunity'

Create E-mail Alert Related Categories

Analyst PT Change, Hot Upgrades, Upgrades

Related Entities

Goldman Sachs

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?